Abbott Laboratories Pakistan LimitedPSX: ABOT

Transmission of Annual Report for the Year Ended 31 December 2024

· Issued by Abbott Laboratories Pakistan Limited

2024 ANNUAL REPORT

Throughout our long history, our focus has never veered from improving the health of people who count on us. We have continuously reinvented Abbott to meet the needs of every age and stage of a person's life.

We believe the best medical products are ones that help the most people. We're well-practiced in delivering through the complexity required to maximize access and affordability across our businesses in branded-generic pharmaceuticals, nutrition, diagnostics and medical devices.

Through its presence in diversified business segments, Abbott has continued to deliver consistent growth and shareholder returns. We're strengthening the resilience of our company so that we can continue to shape the future of healthcare and help more people, in more places, lead fuller, healthier lives.

Table of Contents

02 Vision and Mission

04 Our Core Values

06 History of Major Events

08 Geographical Presence

09 Ownership and Group Structure

10 Corporate Information

11 Organizational Chart

12 Established Pharmaceuticals

14 Nutrition

16 Diagnostics

18 Diabetes Care

20 Key Brands

24 Product Launches

26 Awards and Recognitions

28 Significant factors effecting the external environment and the organization's response

30 Objectives, Strategy and Resource

Allocation Plans

32 Key resources and capabilities of the company which provides sustainable competitive advantage

Our Vision

  • 33 SWOT Analysis

  • 34 Risks and Opportunities

  • 36 Key Risks & Opportunities

  • 38 Sustainability and Corporate Social Responsibility

  • 44 CEO's Message

  • 46 Directors' Profiles

  • 48 Corporate Governance

  • 53 Salient Features of Terms of Reference of Board Committees

  • 54 Board Committees Attendance

  • 55 Gender Pay Gap Statement

  • 56 Stakeholders Relationship and Engagement

  • 57 Future Outlook

  • 58 Review Report by the Chairman

  • 59 Review Report by the Chairman (Urdu)

  • 60 Directors' Report

  • 71 Directors' Report (Urdu)

  • 72 2024 Financial Report

To be the most admired healthcare company in Pakistan.

Our Mission

To deliver consistently superior products and services which contribute significantly to improve the quality of life of consumers.

Our Core Values

Our purpose as a business is clear: we help people live healthier, fuller lives through our life-changing products, solutions and technologies.

Four core values guide how we support this purpose every day.

PIONEERING

We see needs first and deliver game-changing solutions. We create new technologies and products to help people live fuller lives through better health, and we bring that same spirit of innovation to everything we do as a company.

ACHIEVING

We focus relentlessly on delivering for our stakeholders. Abbott is all about execution. Millions of people depend on us in vital ways. We're committed to honoring that trust.

CARING

We treat the people who depend on us as if they were our family. Dr. Abbott began our company to provide better care to his own patients. That spirit still guides everything we do.

ENDURING

We know that everything we do today should contribute to a stronger tomorrow. Because our work is so important to so many, it's up to us to ensure that this company keeps thriving. That's why we think and act for the long term. We intend to be here for the long-term, bringing all the benefits that Abbott creates to all the people who need them.

VALUES BUILD VALUE

Our diversified business model proved its power again in 2024. We grew organically across our businesses, focused on most important healthcare needs, balancing present and future.

History of Major Events

Dr. Abbott breaks ground for a new manufacturing facility in North Chicago, Illinois. This location will serve as the Company's headquarters for more than 40 years.

1920

1973

The global Abbott Diagnostics Division is formed to bring together the Company's diagnostic products and services.

Ensure, Abbott's first adult medical nutritional supplement, is introduced.

2001

Abbott acquires the pharmaceutical business of BASF, including the global operations of Knoll Pharmaceuticals. Vysis, Inc., a leading genomic disease management company, is also acquired.

Abbott Diabetes Care is created with the acquisition of Thera Sense Inc., a leading blood glucose monitoring business. Abbott also acquires EAS Inc., a leader in performance nutrition products.

2004

2010

Abbott separates into two leading healthcare companies, a diversified medical products company under the Abbott name and a research based pharmaceutical company, named AbbVie.

2014

Abbott acquires St. Jude Medical. The acquisition strengthens Abbott's presence in cardiovascular area, thus making Abbott a premier medical device Company. Abbott also acquires Alere, a company focusing on cardiometabolic, infectious disease and toxicology testing.

Abbott acquires Solvay Pharmaceuticals, the global pharmaceutical business of the Solvay Group and STARLIMS Technologies.

2013

Abbott acquires the control of CFR Pharmaceutical thereby establishing Abbott among top pharmaceutical companies in Latin America. Abbott also acquires control of Veropharm, a leading pharmaceutical manufacturer in Russia.

2017

Geographical Presence

- Global & Local Footprints

UNITED STATES, LATIN AMERICA AND CANADA

Illinois - Abbott Park - Head Office

Argentina Brazil Canada Chile Colombia Costa Rica Dominican Republic Ecuador

El Salvador Guatemala Mexico Peru Puerto Rico Trinidad and Tobago Uruguay

EUROPE

Albania Armenia Austria Azerbaijan Belarus Belgium Bosnia-Herzegovina Bulgaria

Croatia

Czech Republic Denmark Estonia Finland France Georgia Germany Greece Hungary Ireland Italy Kazakhstan Latvia Lithuania Moldova Netherlands Norway Poland Portugal

Republic of Serbia Romania

Russian Federation Slovakia

Slovenia Spain Sweden Switzerland Turkey Ukraine

United Kingdom Uzbekistan

MIDDLE EAST AND AFRICA

Algeria Egypt Israel Kuwait Lebanon Saudi Arabia South Africa Tunisia

United Arab Emirates

ASIA PACIFIC

Australia

China Hong Kong India Indonesia Japan Malaysia New Zealand Pakistan Philippines Singapore South Korea Taiwan Thailand Vietnam

Attention: This is an excerpt of the original content. To continue reading it, access the original document here.